August 11, 2016
Genome BC’s Entrepreneurship and Commercialization initiative has led two significant investments in recent months, one into entrepreneurship@UBC (e@UBC) and the other into the BC Technology Industry Association (BCTIA).
The initial 24-month e@UBC partnership includes the establishment of a life sciences program and seed fund at e@UBC with the goal of creating commercially viable business models and converting life science innovations into new ventures. Genome BC’s investment at e@UBC is contributing qualified advice through mentors and entrepreneurs, and early stage risk capital.
Genome BC collaborated with the BCTIA to launch HyperGrowth: Life, BC’s first cohort-based program designed to advance tech companies in the healthtech and life sciences industries. HyperGrowth: Life is a 12-month cohort-based program providing revenue and sales support to growth-stage tech companies in healthtech, digital health, life sciences, agritech and related industries. There were three successful companies in the first cohort: HeadCheck Health, Navigate Surgical Technologies, and ViewsIQ.
